Morgan R, Hazard E, Savage S, Halbert C, Gattoni-Celli S, Hardiman G
Genes (Basel). 2025; 16(2).
PMID: 40004558
PMC: 11855151.
DOI: 10.3390/genes16020229.
Kolenda T, Guglas K, Stasiak M, Poter P, Kozlowska-Maslon J, Bialas P
EXCLI J. 2025; 23:1375-1396.
PMID: 39764216
PMC: 11701299.
DOI: 10.17179/excli2024-7719.
Zhang W, Wu C, Huang H, Bleu P, Zambare W, Alvarez J
Transl Oncol. 2025; 52():102238.
PMID: 39754813
PMC: 11754497.
DOI: 10.1016/j.tranon.2024.102238.
Daneshmand-Parsa M, Nikpour P
Iran J Basic Med Sci. 2024; 27(11):1456-1463.
PMID: 39386228
PMC: 11459342.
DOI: 10.22038/ijbms.2024.74686.16216.
Golara A, Kozlowski M, Cymbaluk-Ploska A
Int J Mol Sci. 2024; 25(18).
PMID: 39337410
PMC: 11432782.
DOI: 10.3390/ijms25189922.
Targeted gene sequencing and transcriptome sequencing reveal characteristics of NUP98 rearrangement in pediatric acute myeloid leukemia.
Zhang J, Chen C, Qin J, Shen D, Liu L, Song H
Eur J Med Res. 2024; 29(1):448.
PMID: 39223643
PMC: 11370121.
DOI: 10.1186/s40001-024-02042-9.
The Spatio-Temporal Expression Profiles of Silkworm Pseudogenes Provide Valuable Insights into Their Biological Roles.
Wan L, Su S, Liu J, Zou B, Jiang Y, Jiao B
Evol Bioinform Online. 2024; 20:11769343241261814.
PMID: 38883803
PMC: 11179516.
DOI: 10.1177/11769343241261814.
Exploring the enigma: history, present, and future of long non-coding RNAs in cancer.
Naseer Q, Malik A, Zhang F, Chen S
Discov Oncol. 2024; 15(1):214.
PMID: 38847897
PMC: 11161455.
DOI: 10.1007/s12672-024-01077-y.
Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.
Zhou W, Yang Y, Wang W, Yang C, Cao Z, Lin X
Cell Cycle. 2024; 23(6):645-661.
PMID: 38842275
PMC: 11229759.
DOI: 10.1080/15384101.2024.2353554.
Pseudogene CSPG4P12 inhibits colorectal cancer progression by attenuating epithelial-mesenchymal transition.
Song Q, Xu H, Wu H, Dong J, Ji S, Zhang X
Braz J Med Biol Res. 2024; 57():e13645.
PMID: 38808892
PMC: 11136487.
DOI: 10.1590/1414-431X2024e13645.
Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia.
Head S, Dezem F, Todor A, Yang J, Plummer J, Gayther S
Am J Hum Genet. 2024; 111(6):1084-1099.
PMID: 38723630
PMC: 11179407.
DOI: 10.1016/j.ajhg.2024.04.012.
microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review.
Giordo R, Ahmadi F, Husaini N, Al-Nuaimi N, Ahmad S, Pintus G
Noncoding RNA Res. 2024; 9(3):831-852.
PMID: 38586315
PMC: 10995982.
DOI: 10.1016/j.ncrna.2024.03.013.
- and -eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia.
Head S, Dezem F, Todor A, Yang J, Plummer J, Gayther S
bioRxiv. 2023; .
PMID: 38014246
PMC: 10680675.
DOI: 10.1101/2023.11.09.566218.
Pseudogenes in Cancer: State of the Art.
Nakamura-Garcia A, Espinal-Enriquez J
Cancers (Basel). 2023; 15(16).
PMID: 37627052
PMC: 10452131.
DOI: 10.3390/cancers15164024.
High level of complexity and global diversity of the 3q29 locus revealed by optical mapping and long-read sequencing.
Yilmaz F, Gurusamy U, Mosley T, Hallast P, Kim K, Mostovoy Y
Genome Med. 2023; 15(1):35.
PMID: 37165454
PMC: 10170684.
DOI: 10.1186/s13073-023-01184-5.
Competing endogenous RNA (ceRNA) networks in Parkinson's disease: A systematic review.
Asadi M, Abed S, Kouchakali G, Fattahi F, Sabaie H, Moslehian M
Front Cell Neurosci. 2023; 17:1044634.
PMID: 36761351
PMC: 9902725.
DOI: 10.3389/fncel.2023.1044634.
Functional Characterization of a Phf8 Processed Pseudogene in the Mouse Genome.
St-Germain J, Khan M, Bavykina V, Desmarais R, Scott M, Boissonneault G
Genes (Basel). 2023; 14(1).
PMID: 36672913
PMC: 9859284.
DOI: 10.3390/genes14010172.
Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues.
Rothzerg E, Feng W, Song D, Li H, Wei Q, Fox A
Cancer Inform. 2022; 21:11769351221140101.
PMID: 36507075
PMC: 9730017.
DOI: 10.1177/11769351221140101.
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.
Tan L, Qin Y, Xie R, Xia T, Duan X, Peng L
Theranostics. 2022; 12(17):7267-7288.
PMID: 36438489
PMC: 9691354.
DOI: 10.7150/thno.76689.
Pseudogene CSPG4P12 affects the biological behavior of non‑small cell lung cancer by Bcl‑2/Bax mitochondrial apoptosis pathway.
Hu W, Wu H, Li A, Zheng X, Zhang W, Tian Q
Exp Ther Med. 2022; 24(6):734.
PMID: 36382103
PMC: 9641161.
DOI: 10.3892/etm.2022.11670.